The Hong Kong Stock Pharmaceutical ETF Yinhua announced that its underlying index securities, Minimally Invasive Healthcare and Minimally Invasive Robot-B, have been suspended since September 1, 2026, and are still suspended until the close of trading on September 4, 2026. In order to protect the interests of fund share holders, as agreed with the fund custodian, starting from September 7, 2026, when investors purchase and redeem the fund, the settlement of the subscription cash in lieu of refunds and cash alternatives corresponding to the above two securities will be handled according to the actual transaction costs after the resumption of trading, or the settlement costs will be adjusted according to the valuation price; if changes in equity such as dividends or stock transfers occur during the period, no separate announcement will be made after the resumption of trading.

The Hong Kong Stock Pharmaceutical ETF Yinhua announced that its underlying index securities, Minimally Invasive Healthcare and Minimally Invasive Robot-B, have been suspended since September 1, 2026, and are still suspended until the close of trading on September 4, 2026. In order to protect the interests of fund share holders, as agreed with the fund custodian, starting from September 7, 2026, when investors purchase and redeem the fund, the settlement of the subscription cash in lieu of refunds and cash alternatives corresponding to the above two securities will be handled according to the actual transaction costs after the resumption of trading, or the settlement costs will be adjusted according to the valuation price; if changes in equity such as dividends or stock transfers occur during the period, no separate announcement will be made after the resumption of trading.